Virus-associated arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 17, Issue 2, 2003, Pages 309-318

  Masuko Hongo, Kayo ^a   Kato, Tomohiro ^a   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HAAP; Hepatitis C virus; HTLV 1; Rubella virus; Tax; Virus

Indexed keywords

ALPHA INTERFERON; ANTIRHEUMATIC AGENT; AUTOANTIGEN; CORTICOSTEROID; FAS ANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VIRUS ANTIGEN; CYTOKINE RECEPTOR ANTAGONIST; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN M; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTHRITIS; ARTHROPATHY; AUTOIMMUNITY; CLINICAL FEATURE; CROSS REACTION; DISEASE MODEL; DRUG EFFICACY; GENE EXPRESSION; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATORY DISEASE; LABORATORY TEST; LIVER TOXICITY; LOW DRUG DOSE; NONHUMAN; PARVOVIRUS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RUBELLA VIRUS; SYNOVITIS; TARGET CELL; VIRUS INFECTION; ANTIGEN PRESENTING CELL; CELL PROLIFERATION; CHRONIC ARTHRITIS; SUBCUTANEOUS NODULE; T LYMPHOCYTE; VIRUS DETECTION; VIRUS TRANSMISSION;

EID: 0038719659     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6942(03)00004-4     Document Type: Review

References (41)

1. Lehky TJ, Cowan CE, Lampson LA & Jacobson S. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. Journal of Virology 1994; 68: 1854-1863.
2. Yewdell JW & Bennink JR. Mechanisms of viral interference with MHC class I antigen processing and presentation. Annual Review of Cell Development Biology 1999; 15: 579-606.
3. Zhu J. Ultraviolet B irradiation and cytomegalovirus infection synergize to induce the cell surface expression of 52 kDa/Ro antigen. Clinical & Experimental Immunology 1996; 103: 47-53.
4. Epstein F. Molecular mimicry and autoimmunity. New England Journal of Medicine 1999; 341: 2068-2074.
5. Benoist C & Mathis D. Autoimmunity provoked by infection: How good is the case for T cell epitope mimicry? Nature Immunology 2001; 2: 797-801.
6. Uchiyama T, Yodoi J, Sagawa K et al. Adult T-cell leukaemia: Clinical and hematologic features of 16 cases. Blood 1977; 50: 481-492.
7. Takatsuki K, Yamaguchi K, Kawano F et al. Cancer Research 1985; 45(supplement): 4644s-4645s.
8. Bangham C. HTLV-1 infections. Journal of Clinical Pathology 2000; 53: 581-586.
9. Kwok RP, Laurence M, Lundblad JR et al. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 1996; 380: 642-646.
10. Aono H, Fujisawa K, Hasunuma T et al. Extracellular human T cell leukaemia virus type I Tax protein stimulates the proliferation of human synovial cells. Arthritis & Rheumatism 1998; 41: 1995-2003.
11. Hasunuma T, Sumida T & Nishioka K. Human T cell leukaemia virus type 1 and rheumatoid arthritis. International Review of Immunology 1998; 17: 291-307.
12. Nishioka K, Maruyama I, Sato K et al. Chronic inflammatory arthropathy associated with HTLV-1. Lancet 1989; i: 441.
13. Iwakura Y, Tosu M, Yoshida E et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science 1991; 253: 1026-1028.
14. Kitajima I, Yamamoto K, Sato K et al. Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. Journal of Clinical Investigation 1991; 88: 1315-1322.
15. Nakajima T, Aono H, Hasunuma T et al. Overgrowth of human synovial cells driven by the human T cell leukaemia virus 1 tax gene. Journal of Clinical Investigation 1993; 92: 186-193.
16. Johnson JM, Harrod R & Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus type-1 (HTLV-1). International Journal of Experimental Pathology 2001; 82: 135-147.
17. Nakazawa M, Hasunuma T, Ohshima T et al. CBP: A target molecule of HTLV-1 Tax in synoviocyte activation. Biochemical & Biophysical Research Communications 2000; 269: 584-590.
18. Mori N, Shirakawa F, Abe M et al. Human T-cell leukaemia virus type I tax transactivates the interleukin-6 gene in human rheumatoid synovial cells. Journal of Rheumatology 1995; 22: 2049-2054.
19. Iwakura Y, Saijo S, Kioka Y et al. Autoimmunity induction by human T cell leukaemia virus type I in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. Journal of Immunology 1995; 155: 1588-1598.
20. Yamamoto K, Aono H, Nakajima T et al. Oligoclonal proliferation of human T-cell leukaemia virus type I infected lymphocytes in lesions of virus-induced arthropathy. Biochemical & Biophysical Research Communications 1995; 208: 1040-1050.
21. Fujisawa K, Okamoto K, Asahara H et al. Evidence for autoantigens of Env/Tax proteins in human T cell leukaemia type I Env-pX transgenic mice. Arthritis & Rheumatism 1998; 41: 1998.
22. Kotani M, Tagawa Y & Iwakura Y. Involvement of autoimmunity against type II collagen in the development of arthritis in mice transgenic for the human T cell leukaemia virus type I tax gene. European Journal of Immunology 1999; 29: 54-64.
23. Jeffery KJ, Usukuu K, Hall SE et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proceedings of the National Academy of Sciences of the USA 1999; 96: 3848-3853.
24. Iwakura Y, Itagaki K, Ishitsuka C et al. The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukaemia virus type-I env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen. Journal of Immunology 1998; 161: 6592-6598.
25. Kobayashi T, Okamotok K, Kobata T et al. Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. Current Opinion in Rheumatology 1999; 11: 188-193.
26. Fujisawa K, Asahara H, Okamoto K et al. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. Journal of Clinical Investigation 1996; 98: 271-278.
27. Deiss V, Tratschin JD, Weitz M & Siegl G. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology 1990; 175: 247-254.
28. Pattison JR, Jones SE, Hodgson J et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981;i:664-665.
29. Woolf AD, Campion GV, Chishick A et al. Clinical manifestations of human parvovirus B19 in adults. Archives of Internal Medicine 1989; 149: 1153-1156.
30. Joseph PR. Fifth disease: The frequency of joint involvement in adults. New York State Journal of Medicine 1986; 86: 560-563.
31. Gran JT, Johnsen V, Myklebust G & Nordbo SA. The variable clinical picture of arthritis induced by human parvovirus B19. Report of seven adult cases and review of the literature. Scandinavian Journal of Rheumatology 1995; 24: 174-179.
32. Tyndall A, Jelk W amp; Hirsch HH. Parvovirus B19 and erosive polyarthritis. Lancet 1994; 343: 480-481.
33. Takahashi Y, Murai C, Shibata S et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proceedings of the National Academy of Sciences of the USA 1998; 95: 8227-8232.
34. Moffatt S, Tanaka N, Tada K et al. A cytotoxic nonstructural protein, NSI, of human parvovirus B19 induces activation of interleukin-6 gene expression. Journal of Virology 1996; 70: 8485-8491.
35. Fu Y, Ishii KK, Munakata Y et al. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. Journal of Virology 2002; 76: 5395-5403.
36. Gendi NS, Gibson K & Wordsworth BP. Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: One year follow up of an outbreak. Annals of the Rheumatic Diseases 1996; 55: 63-65.
37. Zuckerman E, Keren D, Rozenbaum M et al. Hepatitis C virus-related arthritis: Characteristics and response to therapy with interferon alpha. Clinical & Experimental Rheumatology 2000; 18: 579-584.
38. Zuckerman E, Yeshurun D amp; Rosner I. Management of hepatitis C virus-related arthritis. BioDrugs 2001; 15: 573-584.
39. Smith CA, Petty RE & Tingle AJ. Rubella virus and arthritis. Rheumatic Disease Clinics of North America 1987; 13: 265-274.
40. Frenkel LM, Nielsen K, Garakian A et al. A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis. Clinical Infectious Diseases 1996; 22: 287-294.
41. Slater PE, Ben-Zvi T, Fogel A et al. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women. Vaccine 1995; 13: 1529-1532.